Literature DB >> 23743043

Decentralisation of multidrug-resistant-tuberculosis care and management.

Helen Cox1, Nathan Ford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23743043     DOI： 10.1016/S1473-3099(13)70151-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  8 in total

1.  Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.

Authors:  Stellah G Mpagama; Norah Ndusilo; Suzanne Stroup; Happiness Kumburu; Charles A Peloquin; Jean Gratz; Eric R Houpt; Gibson S Kibiki; Scott K Heysell
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

2.  Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.

Authors:  Mathieu Bastard; Elisabeth Sanchez-Padilla; Philipp du Cros; Atadjan Karimovich Khamraev; Nargiza Parpieva; Mirzagaleg Tillyashaykov; Armen Hayrapetyan; Kamene Kimenye; Shazina Khurkhumal; Themba Dlamini; Santiago Fadul Perez; Alex Telnov; Cathy Hewison; Francis Varaine; Maryline Bonnet
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

3.  Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences.

Authors:  Gerard de Vries; Svetla Tsolova; Laura F Anderson; Agnes C Gebhard; Einar Heldal; Vahur Hollo; Laura Sánchez-Cambronero Cejudo; Daniela Schmid; Bert Schreuder; Tonka Varleva; Marieke J van der Werf
Journal:  BMC Public Health       Date:  2017-04-19       Impact factor: 3.295

4.  The experience of scaling up a decentralized, ambulatory model of care for management of multidrug-resistant tuberculosis in two regions of Ethiopia.

Authors:  Yohannes Molla; Degu Jerene; Ilili Jemal; Gebrie Nigussie; Tenagne Kebede; Yewulsew Kassie; Nebiyu Hiruy; Getachew Aschale; Dereje Habte; Zewdu Gashu; Yared Kebede Haile; Muluken Melese; Pedro Suarez
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-03-06

5.  Barriers to Buruli ulcer treatment completion in the Ashanti and Central Regions, Ghana.

Authors:  Shelui Collinson; Venus N B Frimpong; Bernadette Agbavor; Bethany Montgomery; Michael Oppong; Michael Frimpong; Yaw A Amoako; Michael Marks; Richard O Phillips
Journal:  PLoS Negl Trop Dis       Date:  2020-05-26

Review 6.  Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis.

Authors:  Pamela Weiss; Wenjia Chen; Victoria J Cook; James C Johnston
Journal:  BMC Infect Dis       Date:  2014-06-17       Impact factor: 3.090

Review 7.  Impact of Community-Based DOT on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis.

Authors:  HaiYang Zhang; John Ehiri; Huan Yang; Shenglan Tang; Ying Li
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

8.  Preparedness of outpatient health facilities for ambulatory treatment with all-oral short DR-TB treatment regimens in Zhytomyr, Ukraine: a cross-sectional study.

Authors:  Tinne Gils; Chinmay Laxmeshwar; Marve Duka; Khachatur Malakyan; Olga Valentinovna Siomak; Vitaly Stephanovich Didik; Natalia Lytvynenko; Yana Terleeva; Dmytri Donchuk; Petros Isaakidis
Journal:  BMC Health Serv Res       Date:  2020-09-21       Impact factor: 2.655
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.